Hybrigenics SA 3HB-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 07/01/22 CEST
0.1314UNCH (UNCH)
52 week range
0.09 - 0.21
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.1314
  • 52 Week High0.21
  • 52 Week High Date07/29/21
  • 52 Week Low0.09
  • 52 Week Low Date03/08/22

Key Stats

  • Market Cap37.4M
  • Shares Out261.25M
  • 10 Day Average Volume23,477.08
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change12.5

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.1314
  • 52 Week High0.21
  • 52 Week High Date07/29/21
  • 52 Week Low0.09
  • 52 Week Low Date03/08/22
  • Market Cap37.4M
  • Shares Out261.25M
  • 10 Day Average Volume23,477.08
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change12.5

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Hybrigenics SA

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Hybrigenics SA is France-based Company engaged in the biotechnological sector. It specializes in the research and development of drugs intended for cancer treatment and supplies scientific services in the protein interaction field. The Company is specialized in the research and development (R&D) of drugs to fight cancer. It is organized in two units: Hybrigenics Pharma for internal R&D, which develops a research program aimed at such diseases as melanoma and prostate cancer;...
Jean-Paul Ansel
Chairman of the Board
Julien Gauthier
Chief Executive Officer
Address
3-5 impasse Reille
Paris
75014
France